Prot# ALXN1210-aHUS-311: Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients with Atypical Hemolytic Uremic Syndrome (aHUS)

Project: Research project

Project Details

StatusActive
Effective start/end date1/8/181/8/21

Funding

  • Quintiles, Inc. (ALXN1210-aHUS-311)
  • Alexion Pharmaceuticals, Inc. (ALXN1210-aHUS-311)